Differential effects of interleukin-12 and interleukin-15 on expansion of NK cell receptor-expressing CD8+ T cells

Annals of Hematology

Volumn 89, Issue 2, 2010, Pages 115-120

  Sugita, Junichi ^a   Tanaka, Junji ^a   Yasumoto, Atsushi ^a   Shiratori, Souichi ^a   Wakasa, Kentaro ^a   Kikuchi, Misato ^a   Shigematsu, Akio ^a   Kondo, Takeshi ^a   Asaka, Masahiro ^a   Imamura, Masahiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CD94; Cytolytic activity; NKG2A; NKG2D

Indexed keywords

CD94 ANTIGEN; GRANZYME A; INTERLEUKIN 12; INTERLEUKIN 15; MESSENGER RNA; MONOCLONAL ANTIBODY CD3; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY C; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY D; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K;

ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELL ASSAY; CELL COUNT; CELL EXPANSION; CELL SIZE; CONTROLLED STUDY; CYTOSOL; GENE EXPRESSION; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; ADULT; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; FLOW CYTOMETRY; METABOLISM; POLYMERASE CHAIN REACTION;

ADULT; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-12; INTERLEUKIN-15; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; POLYMERASE CHAIN REACTION;

EID: 74049109004     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-009-0780-0     Document Type: Article

References (26)

1. Ljunggren HG, Karre K (1990) In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 11:237-244.
2. Phillips JH, Gumperz JE, Parham P, Lanier LL (1995) Superantigen- dependent, cell-mediated cytolyticity inhibited by MHC class I receptors on T lymphocytes. Science 268:403-405.
3. Mingari MC, Schiavetti F, Ponte M, Vitale C, Maggi E, Romagnani S, Demarest J, Pantaleo G, Fauci AS, Moretta L (1996) Human CD8 + T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci U S A 93:12433-12438.
4. Moretta A, Biassoni R, Bottino C, Pende D, Vitale M, Poggi A, Mingari MC, Moretta L (1997) Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev 155:105-117.
5. Bakker AB, Phillips JH, Figdor CG, Lanier LL (1998) Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL. J Immunol 160:5239-5245.
6. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285:727-729.
7. Wu J, Song Y, Bakker AB, Bauer S, Spies T, Lanier LL, Phillips JH (1999) An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285:730-732.
8. Huard B, Karlsson L (2000) KIR expression on self-reactive CD8 + T cells is controlled by T-cell receptor engagement. Nature 403:325-328.
9. Ulbrecht M, Honka T, Person S, Johnson JP, Weiss EH (1992) The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein. J Immunol 149:2945-2953.
10. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG (1998) Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 187:813-818.
11. Braud VM, Allan DS, O'Callaghan CA, Soderstrom K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ (1998) HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391:795-799.
12. Derre L, Corvaisier M, Pandolfino MC, Diez E, Jotereau F, Gervois N (2002) Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapy. J Immunol 168:4864-4870.
13. Vivier E, Tomasello E, Paul P (2002) Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition? Curr Opin Immunol 14:306-311.
14. Raulet DH (2003) Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3:781-790.
15. Tanaka J, Toubai T, Miura Y, Tsutsumi Y, Kato N, Umehara S, Toyoshima N, Ohta S, Asaka M, Imamura M (2004) Differential expression of natural killer cell receptors (CD94/NKG2A) on T cells by the stimulation of G-CSF-mobilized peripheral blood mononuclear cells with anti-CD3 monoclonal antibody and cytokines: a study in stem cell donors. Transplant Proc 36:2511-2512.
16. Mingari MC, Ponte M, Bertone S, Schiavetti F, Vitale C, Bellomo R, Moretta A, Moretta L (1998) HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigenactivated CD8+ T cells. Proc Natl Acad Sci U S A 95:1172-1177.
17. Tanaka J, Toubai T, Tsutsumi Y, Miura Y, Kato N, Umehara S, Kahata K, Mori A, Toyoshima N, Ota S, Kobayashi T, Kobayashi M, Kasai M, Asaka M, Imamura M (2004) Cytolytic activity and regulatory functions of inhibitory NK cell receptor-expressing T cells expanded from granulocyte colony-stimulating factormobilized peripheral blood mononuclear cells. Blood 104:768-774.
18. Tanaka J, Iwao N, Toubai T, Tsutsumi Y, Miura Y, Kato N, Shigematsu A, Yamane M, Ota S, Kondo T, Kobayashi T, Takeda H, Kobayashi M, Asaka M, Imamura M (2005) Cytolytic activity against primary leukemic cells by inhibitory NK cell receptor (CD94/NKG2A)-expressing T cells expanded from various sources of blood mononuclear cells. Leukemia 19:486-489.
19. Zeddou M, Greimers R, de Valensart N, Nayjib B, Tasken K, Boniver J, Moutschen M, Rahmouni S (2005) Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway. Biochem Pharmacol 70:714-724.
20. Bertone S, Schiavetti F, Bellomo R, Vitale C, Ponte M, Moretta L, Mingari MC (1999) Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes. Eur J Immunol 29:23-29.
21. Gunturi A, Berg RE, Crossley E, Murray S, Forman J (2005) The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells. Eur J Immunol 35:766-775.
22. Dhanji S, Teh HS (2003) IL-2-activated CD8+CD44high cells express both adaptive and innate immune system receptors and demonstrate specificity for syngeneic tumor cells. J Immunol 171:3442-3450.
23. Verneris MR, Karami M, Baker J, Jayaswal A, Negrin RS (2004) Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells. Blood 103:3065-3072.
24. Karimi M, Cao TM, Baker JA, Verneris MR, Soares L, Negrin RS (2005) Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells. J Immunol 175:7819-7828.
25. Ortaldo JR, Winkler-Pickett R, Wigginton J, Horner M, Bere EW, Mason AT, Bhat N, Cherry J, Sanford M, Hodge DL, Young HA (2006) Regulation of ITAM-positive receptors: role of IL-12 and IL-18. Blood 107:1468-1475.
26. RobertsAI, Lee L, Schwarz E, GrohV, Spies T, Ebert EC, Jabri B(2001) NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J Immunol 167:5527-5530.